Urology Consulting: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Urology Consulting
Largest movements
- Cash -€3,635
down €3,635 (-81.7%), from €4,449 to €814
mainly Net result for the year (-€2,128) and Receivables within one year (-€2,060)
- Receivables within one year +€2,060
up €2,060 (+92.0%), from €2,240 to €4,300
- Tangible fixed assets -€230
no longer reported in 2025 (was €230)
- Profit (loss) carried forward -€2,128
down €2,128 (-68.2%), from €3,122 to €994
- Trade debts +€743
up €743 (+197%), from €377 to €1,120
- Tax, wage and social debts -€413
no longer reported in 2025 (was €413)
- Gross operating margin -€7,872
down €7,872, from €6,745 to -€1,128
- Taxes -€413
no longer reported in 2025 (was €413)
- Depreciation -€332
down €332 (-59.1%), from €562 to €230
- Financial charges +€225
up €225 (+154%), from €146 to €371
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,918 | €5,114 | -€1,804 | -26.1% |
| Fixed assets | 21/28 | €230 | - | -€230 | |
| Tangible fixed assets | 22/27 | €230 | - | -€230 | |
| Furniture and vehicles | 24 | €230 | - | -€230 | |
| Current assets | 29/58 | €6,689 | €5,114 | -€1,575 | -23.5% |
| Amounts receivable within one year | 40/41 | €2,240 | €4,300 | +€2,060 | +92.0% |
| Trade receivables | 40 | €2,240 | €4,300 | +€2,060 | +92.0% |
| Cash at bank and in hand | 54/58 | €4,449 | €814 | -€3,635 | -81.7% |
| Total equity and liabilities | 10/49 | €6,918 | €5,114 | -€1,804 | -26.1% |
| Equity | 10/15 | €6,122 | €3,994 | -€2,128 | -34.8% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €3,122 | €994 | -€2,128 | -68.2% |
| Amounts payable | 17/49 | €796 | €1,120 | +€323 | +40.6% |
| Amounts payable within one year | 42/48 | €796 | €1,120 | +€323 | +40.6% |
| Trade debts | 44 | €377 | €1,120 | +€743 | +197% |
| Suppliers | 440/4 | €377 | €1,120 | +€743 | +197% |
| Taxes, remuneration and social security | 45 | €413 | - | -€413 | |
| Taxes | 450/3 | €413 | - | -€413 | |
| Other amounts payable | 47/48 | €6 | - | -€6 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €562 | €230 | -€332 | -59.1% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €6,745 | -€1,128 | -€7,872 | |
| Operating profit (loss) | 9901 | €5,795 | -€1,757 | -€7,553 | |
| Financial charges | 65/66B | €146 | €371 | +€225 | +154% |
| Recurring financial charges | 65 | €146 | €371 | +€225 | +154% |
| Profit (loss) for the period before taxes | 9903 | €5,650 | -€2,128 | -€7,777 | |
| Income taxes | 67/77 | €413 | - | -€413 | |
| Profit (loss) for the period | 9904 | €5,236 | -€2,128 | -€7,364 | |
| Profit (loss) for the period to be appropriated | 9905 | €5,236 | -€2,128 | -€7,364 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.